Sort
64,565 grants matching “drug discovery”
CIF: IHCS: Medium: Collaborative Research: Design and Implementation of Position-Encoded 3D Microarrays
$838,820Arye Nehorai · Washington University · · FY2010 · CSE
Using monoclonal antibody Fc variants in strategies to eliminate HIV reservoirs
$838,801Ann Jones Hessell · Oregon Health & Science University · R01 · FY2020 · AI
Pharmacogenomics of HIV Therapy
$838,752David W Haas · Vanderbilt University Medical Center · R01 · FY2021 · AI
Targeting superbugs: discovery and development of new broad-spectrum lipopeptides
$838,537Jian Li · Monash University · R01 · FY2015 · AI
Psychiatric Genomics Consortium for PTSD
$838,502Caroline M Nievergelt · University Of California, San Diego · R01 · FY2017 · MH
VGER, the Vanderbilt Genome-Electronic Records Project
$838,369Dan M Roden · Vanderbilt University · U01 · FY2015 · HG
VGER, the Vanderbilt Genome-Electronic Records Project
$838,369Dan M Roden · Vanderbilt University Medical Center · U01 · FY2016 · HG
VGER, the Vanderbilt Genome-Electronic Records Project
$838,369Dan M Roden · Vanderbilt University Medical Center · U01 · FY2018 · HG
Predicting Chemotherapy-Induced Mucositis with Genetic and Clinical Factors
$838,366Elizabeth Ann Coleman · Univ Of Arkansas For Med Scis · RC2 · FY2009 · NR
Targeting S-adenosylmethionine decarboxylase for HAT drug discovery
$838,349Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2012 · AI
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models
$838,304Bingshan Li · Vanderbilt University · R01 · FY2021 · AG
Institute for Clinical and Translational Research (UL1)
$838,278Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2009 · RR
Identification and Development of Anti-Flavivirus Lead Drug Candidates
$838,268Jay A Nelson · University Of Alabama At Birmingham · U19 · FY2016 · AI
Target based discovery of next generation pyrazinamide
$838,267Veronique Dartois · Hackensack University Medical Center · R01 · FY2019 · AI
Towards Evidence-Based Monitoring of Low Dose Methotrexate: CIRT Ancillary Study
$838,133Daniel Hal Solomon · Brigham And Women'S Hospital · R01 · FY2018 · HL
A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution
$837,842Robin Prince · Fluid Discovery Inc · R42 · FY2022 · GM
Translational Center on Serotonin and Stimulant Addiction
$837,809Kathryn A. Cunningham · University Of Texas Med Br Galveston · P20 · FY2008 · DA
Countermeasures for Bioterroism Targeting Cellular Host Factors
$837,768John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2012 · AI
Drug Discovery for Chagas Disease
$837,654Frederick Simmons Buckner · University Of Washington · R01 · FY2022 · AI
Deciphering the amine/acetylation code of PNAG through comprehensive libraries of synthetic oligosaccharides for effective anti-microbial vaccines
$837,644Xuefei Huang · Michigan State University · R01 · FY2025 · AI
Translational Center on Serotonin and Stimulant Addiction
$837,530Kathryn A. Cunningham · University Of Texas Med Br Galveston · P20 · FY2009 · DA
Large-scale Genetic Investigation and Drug Discovery to Counteract Down Syndrome Neural Deficits
$837,498Summer B Thyme · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · HD
Discovery of Pharmacogenomic Biomarkers for Metformin Response
$837,363Kathleen M Giacomini · University Of California, San Francisco · R01 · FY2015 · GM
Diverse drug lead compounds from bacterial symbionts in tropical marine mollusks
$837,345Margo Genevieve Haygood · Oregon Health & Science University · U01 · FY2012 · TW
Diverse drug lead compounds from bacterial symbionts in tropical marine mollusks
$837,345Margo Genevieve Haygood · Oregon Health & Science University · U01 · FY2011 · TW